Spectral MD Holdings Ltd. is a predictive AI company focused on medical diagnostics. The Company's DeepView(R) platform is a predictive diagnostic device which offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. Spectral MD Holdings Ltd., formerly known as ROSECLIFF ACQ, is based in DALLAS.
| Revenue (Most Recent Fiscal Year) | $19.65M |
| Net Income (Most Recent Fiscal Year) | $-7.57M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.53 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -65.78% |
| Net Margin (Trailing 12 Months) | -69.27% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -78.56% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.90 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.85 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 11.96 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.19 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.13 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.41 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.35 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 32.19M |
| Free Float | 27.78M |
| Market Capitalization | $53.43M |
| Average Volume (Last 20 Days) | 0.12M |
| Beta (Past 60 Months) | 1.21 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 13.70% |
| Percentage Held By Institutions (Latest 13F Reports) | 67.08% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |